Cargando…

Huntington’s Disease Clinical Trials Corner: August 2023

In this edition of the Huntington’s Disease Clinical Trials Corner, we expand on the GENERATION HD2 (tominersen) and on the Asklepios Biopharmaceutical/BrainVectis trial with AB-1001. We also comment on the recent findings from the PROOF-HD trial, and list all currently registered and ongoing clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Estevez-Fraga, Carlos, Tabrizi, Sarah J., Wild, Edward J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473124/
https://www.ncbi.nlm.nih.gov/pubmed/37483021
http://dx.doi.org/10.3233/JHD-239001
_version_ 1785100213142159360
author Estevez-Fraga, Carlos
Tabrizi, Sarah J.
Wild, Edward J.
author_facet Estevez-Fraga, Carlos
Tabrizi, Sarah J.
Wild, Edward J.
author_sort Estevez-Fraga, Carlos
collection PubMed
description In this edition of the Huntington’s Disease Clinical Trials Corner, we expand on the GENERATION HD2 (tominersen) and on the Asklepios Biopharmaceutical/BrainVectis trial with AB-1001. We also comment on the recent findings from the PROOF-HD trial, and list all currently registered and ongoing clinical trials in Huntington’s disease.
format Online
Article
Text
id pubmed-10473124
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-104731242023-09-02 Huntington’s Disease Clinical Trials Corner: August 2023 Estevez-Fraga, Carlos Tabrizi, Sarah J. Wild, Edward J. J Huntingtons Dis Clinical Trials Corner In this edition of the Huntington’s Disease Clinical Trials Corner, we expand on the GENERATION HD2 (tominersen) and on the Asklepios Biopharmaceutical/BrainVectis trial with AB-1001. We also comment on the recent findings from the PROOF-HD trial, and list all currently registered and ongoing clinical trials in Huntington’s disease. IOS Press 2023-07-28 /pmc/articles/PMC10473124/ /pubmed/37483021 http://dx.doi.org/10.3233/JHD-239001 Text en © 2023 – The authors. Published by IOS Press https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) License (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Trials Corner
Estevez-Fraga, Carlos
Tabrizi, Sarah J.
Wild, Edward J.
Huntington’s Disease Clinical Trials Corner: August 2023
title Huntington’s Disease Clinical Trials Corner: August 2023
title_full Huntington’s Disease Clinical Trials Corner: August 2023
title_fullStr Huntington’s Disease Clinical Trials Corner: August 2023
title_full_unstemmed Huntington’s Disease Clinical Trials Corner: August 2023
title_short Huntington’s Disease Clinical Trials Corner: August 2023
title_sort huntington’s disease clinical trials corner: august 2023
topic Clinical Trials Corner
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473124/
https://www.ncbi.nlm.nih.gov/pubmed/37483021
http://dx.doi.org/10.3233/JHD-239001
work_keys_str_mv AT estevezfragacarlos huntingtonsdiseaseclinicaltrialscorneraugust2023
AT tabrizisarahj huntingtonsdiseaseclinicaltrialscorneraugust2023
AT wildedwardj huntingtonsdiseaseclinicaltrialscorneraugust2023